Selected Investments
We invest in companies reshaping systems, not just treating symptoms.
DIGITAL HEALTH
A digital toolkit that reinvents dietary assessment and management with an innovative, clinically tested visual approach to optimizing health.
A medical device company developing and commercializing a revolutionary treatment for gastroesophageal reflux disease (GERD).
A company making life better by improving the availability, quality, and safety of mental healthcare for individual patients.
A technology enabled mental healthcare provider that delivers high-quality psychiatric care, responsibly.
Concert is a healthcare technology company enabling cost-effective access to diagnostics and therapeutics by harmonizing evidence, care and payment.
GenomOncology provides trusted infrastructure that empowers labs, clinicians, and researchers to transform fragmented oncology data into confident, next-best decisions.
Xsolis was born from the idea that too many unnecessary silos exist in healthcare, particularly between providers and payers. Our name is intentional because our mission is to leverage data and automation to break down silos (silos-X) and create “frictionless healthcare.”